G. Jung

921 total citations
26 papers, 762 citations indexed

About

G. Jung is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, G. Jung has authored 26 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Immunology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in G. Jung's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Chemical Synthesis and Analysis (5 papers) and Immunotherapy and Immune Responses (3 papers). G. Jung is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Chemical Synthesis and Analysis (5 papers) and Immunotherapy and Immune Responses (3 papers). G. Jung collaborates with scholars based in Germany, France and United States. G. Jung's co-authors include Stefan Stevanović, K H Wiesmüller, Wolfgang G. Bessler, G. Winkelmann, Karl‐Heinz Wiesmüller, Knut Sletten, Morten Skaugen, Ingolf F. Nes, Volker Gnau and Jack L. Strominger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

G. Jung

26 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Jung Germany 15 335 267 124 93 91 26 762
H. W. Wollenweber Germany 13 521 1.6× 390 1.5× 102 0.8× 77 0.8× 96 1.1× 13 1.0k
John E. Somerville United States 17 332 1.0× 299 1.1× 48 0.4× 79 0.8× 71 0.8× 33 1.1k
Alejandra Bernardini Spain 14 447 1.3× 67 0.3× 70 0.6× 65 0.7× 55 0.6× 22 1.0k
Henry J. Windle Ireland 21 365 1.1× 323 1.2× 46 0.4× 207 2.2× 40 0.4× 40 1.3k
Jun Aketagawa Japan 16 254 0.8× 302 1.1× 113 0.9× 132 1.4× 103 1.1× 29 1.0k
Katsuhisa Nakata Japan 15 204 0.6× 128 0.5× 62 0.5× 147 1.6× 54 0.6× 28 710
Vignesh Venkatakrishnan Sweden 21 561 1.7× 305 1.1× 66 0.5× 53 0.6× 51 0.6× 38 962
Y. Ohshima Japan 16 258 0.8× 91 0.3× 82 0.7× 47 0.5× 46 0.5× 55 646
Nobuhiko Kasai Japan 12 334 1.0× 347 1.3× 76 0.6× 25 0.3× 71 0.8× 27 667
Kareen J. I. Thorne United Kingdom 19 342 1.0× 132 0.5× 77 0.6× 52 0.6× 23 0.3× 43 820

Countries citing papers authored by G. Jung

Since Specialization
Citations

This map shows the geographic impact of G. Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Jung more than expected).

Fields of papers citing papers by G. Jung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Jung. The network helps show where G. Jung may publish in the future.

Co-authorship network of co-authors of G. Jung

This figure shows the co-authorship network connecting the top 25 collaborators of G. Jung. A scholar is included among the top collaborators of G. Jung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Jung. G. Jung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Walk, Tilmann, et al.. (2004). Reduced reactivation rate in mutant CuZnSOD and progression rate of amyotrophic lateral sclerosis. European Journal of Neurology. 11(6). 397–404. 3 indexed citations
4.
5.
Winkelmann, G., et al.. (1999). Degradation of desferrioxamines by Azospirillum irakense: Assignment of metabolites by HPLC/electrospray mass spectrometry. BioMetals. 12(3). 255–264. 37 indexed citations
6.
Walk, Tilmann, H Otto, G. Jung, et al.. (1999). Identification of peptides from autoantigens GAD65 and IA-2 that bind to HLA class II molecules predisposing to or protecting from type 1 diabetes.. Diabetes. 48(10). 1937–1947. 32 indexed citations
7.
Warrassꝉ, Ralf, Karl‐Heinz Wiesmüller, & G. Jung. (1998). Cyclic oligocarbamates. Tetrahedron Letters. 39(18). 2715–2716. 11 indexed citations
8.
Fournier, Philippe, G. Jung, Guy A. M. Berbers, et al.. (1997). Antibodies to a new linear site at the topographical or functional interface between the haemagglutinin and fusion proteins protect against measles encephalitis.. Journal of General Virology. 78(6). 1295–1302. 56 indexed citations
9.
Bauser, Marcus, et al.. (1997). Synthesis of hydantoins via N, N′-ureas derived from polymer-bound amino acids. Molecular Diversity. 3(4). 257–260. 4 indexed citations
10.
Wiesmüller, Karl‐Heinz, et al.. (1996). Specificity and degeneracy of minor histocompatibility antigen-specific MHC-restricted CTL. The Journal of Immunology. 156(10). 3645–3651. 45 indexed citations
11.
Meyer, Helmut E., et al.. (1994). Sequence Analysis of Lantibiotics: Chemical Derivatization Procedures Allow a Fast Access to Complete Edman Degradation. Analytical Biochemistry. 223(2). 185–190. 70 indexed citations
12.
Hauschildt, Sunna, H U Beuscher, G. Jung, Wolfgang G. Bessler, & A. J. Ulmer. (1994). Intraperitoneal injection of synthetic bacterial lipopeptides does not cause a rise in circulating inflammatory cytokines. FEMS Immunology & Medical Microbiology. 8(1). 77–82. 4 indexed citations
13.
Skaugen, Morten, et al.. (1994). In vivo conversion of L-serine to D-alanine in a ribosomally synthesized polypeptide.. Journal of Biological Chemistry. 269(44). 27183–27185. 112 indexed citations
14.
Deres, Karl, Werner Beck, Stefan Faath, G. Jung, & Hans‐Georg Rammensee. (1993). MHC/Peptide Binding Studies indicate Hierarchy of Anchor Residues. Cellular Immunology. 151(1). 158–167. 17 indexed citations
15.
Jung, G. & Annette G. Beck‐Sickinger. (1992). ChemInform Abstract: Multiple Peptide Synthesis Methods and Their Applications. ChemInform. 23(29). 6 indexed citations
16.
Beck‐Sickinger, Annette G., et al.. (1992). Semiautomated T-bag peptide synthesis using 9-fluorenyl-methoxycarbonyl strategy and benzotriazol-1-yl-tetramethyl-uronium tetrafluoroborate activation.. PubMed. 4(2). 88–94. 16 indexed citations
17.
Wiesmüller, K H, et al.. (1986). A synthetic analogue of Escherichia coli lipoprotein, tripalmitoyl pentapeptide, constitutes a potent immune adjuvant.. The Journal of Immunology. 137(8). 2676–2681. 66 indexed citations
18.
Deml, G., et al.. (1984). Tetraglycylferrichrome ‐ the first heptapeptide ferrichrome. FEBS Letters. 173(1). 53–57. 20 indexed citations
19.
Küsters, Ernst, Hermann Allgaier, G. Jung, & E. Bayer. (1984). Resolution of sulphur-containing amino acids by chiral phase gas chromatography. Chromatographia. 18(6). 287–293. 35 indexed citations
20.
Wiesmüller, Karl‐Heinz, et al.. (1982). B-lymphocyte mitogenicity in vitro of a synthetic lipopeptide fragment derived from bacterial lipoprotein.. PubMed. 363(7). 767–70. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. W. Wollenweber Breakdown of academic impact, for papers by John E. Somerville Breakdown of academic impact, for papers by Alejandra Bernardini Breakdown of academic impact, for papers by Henry J. Windle Breakdown of academic impact, for papers by Jun Aketagawa Breakdown of academic impact, for papers by Katsuhisa Nakata Breakdown of academic impact, for papers by Vignesh Venkatakrishnan Breakdown of academic impact, for papers by Y. Ohshima Breakdown of academic impact, for papers by Nobuhiko Kasai Breakdown of academic impact, for papers by Kareen J. I. Thorne
Rankless by CCL
2026